AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Evogene Ltd has announced its Annual General Meeting for August 11, 2025, to address proposals including director re-election and compensation amendments. Shareholders of record as of June 23, 2025, are entitled to vote, with the company's board recommending approval. Analysts weigh Evogene's stock down due to weak financial performance and unattractive valuation, despite positive technical signals.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet